Elderly patients with acute coronary syndromes: Higher risk and greater benefit from antithrombotic and interventional therapies

American Journal of Geriatric Cardiology

Volumn 9, Issue 5, 2000, Pages 265-270

  Cannon, C P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ANGIOPLASTY; ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG EFFICACY; ELDERLY CARE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; RISK FACTOR; ST SEGMENT; UNSTABLE ANGINA PECTORIS;

EID: 0034495289     PISSN: 10767460     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1076-7460.2000.80049.x     Document Type: Article

References (21)

1. Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial
2. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
3. ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
4. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75
5. Thrombolytic therapy for patients with myocardial infarction who are older than 75 years: Do the risks outweigh the benefits?
6. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
7. Advances in the medical management of acute coronary syndromes
8. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: Results of the TIMI 10B trial
9. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: The ASSENT-2 double-blind randomised trial
10. Abciximab facilitates the rate and extent of thrombolysis: Results of TIMI 14 trial
11. Abciximab + tPA improves coronary flow in a wide range of subgroups: Results from TIMI 14
12. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction
13. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy of acute myocardial infarction. A quantitative review
14. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease
15. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction: Results of the Thrombolysis In Myocardial Infarction (TIMI) 11B trial
16. Effect of low molecular weight heparin on prespecified patient subgroups with rest unstable angina or non-Q-wave myocardial infarction
17. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
18. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina
19. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction
20. Invasive compared with noninvasive treatment in unstable coronary artery disease: FRISC II prospective randomised multicentre study
21. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q-wave myocardial infarction